PLx Pharma Winddown Corp.
DelistedCIK 1497504fmd_0ND8K4MBYKB8R8QH7X325DKDXPManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 14, 2010 to Sep 30, 2022, 42 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 0 | 0 | 1 | 1 | 1 | 0 | 8 |
| Cost of revenue | – | – | – | – | – | – | – | – | 0 | 5 |
| Gross profit | – | – | – | – | – | – | – | – | 0 | 3 |
| Research and development | – | 2 | 9 | 11 | 0 | 4 | 4 | 5 | 4 | 4 |
| Selling, general and administrative | – | – | – | – | – | – | – | – | 9 | 40 |
| Total operating expenses | – | 4 | 14 | 19 | 5 | 17 | 12 | 15 | 13 | 44 |
| Operating income | – | (4) | (14) | (19) | (5) | (16) | (11) | (14) | (13) | (41) |
| Interest expense | – | – | – | – | 0 | 1 | 1 | 1 | 0 | – |
| Interest and investment income | – | – | – | – | 0 | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | – | – | – | – | (0) | (0) | 12 | (6) | (2) | (5) |
| Income before taxes | – | – | – | – | (5) | (16) | 1 | (21) | (15) | (46) |
| Income tax expense | – | – | 0 | 0 | – | (1) | – | – | 0 | 0 |
| Net income from continuing operations | – | – | – | – | – | (15) | – | – | (15) | (46) |
| Net income | (2) | (4) | (14) | (19) | (5) | (15) | 1 | (21) | (15) | (46) |